• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D-二聚体/纤维蛋白原比值与复发性加重可能对预测 COPD 加重患者 90 天死亡率有潜在影响。

D-dimer/Fibrinogen ratio and recurrent exacerbations might have a potential impact to predict 90-day mortality in patients with COPD exacerbation.

机构信息

University of Health Sciences, Yedikule Chest Disease and Thoracic Surgery Training and Research Hospital, İstanbul, Turkey.

出版信息

Malawi Med J. 2021 Dec;33(4):276-280. doi: 10.4314/mmj.v33i4.8.

DOI:10.4314/mmj.v33i4.8
PMID:35291388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8893003/
Abstract

BACKGROUND

According to the World Health Organisation reports (WHO), COPD is the third leading cause of overall in the World by 2020.

AIM

We aimed to determine the prognostic predictors of 90-day mortality after an initial exacerbation in patients with acute exacerbation of COPD (AECOPD).

RESULTS

Increased Charlson Comorbidity Score(CCS) (HR:1.47; p<0.05), readmission after initial exacerbation (HR:1.47; p<0.05) were predictive risk factors for 30-day mortality in multivariable regression model. The 90-day mortality rate was %11.8. Hypertension, increased median age, nutrition risk score (NRS), CCS, CAT score, and mMRC 4th level were possible risk factors for 90-day mortality. There was a significant difference in the mortality of patients with D-dimer/Fibrinogen ratios>0.11 and ≤0.11 (HR:2.47; p<0.05). Recurrent exacerbations after discharge were predictive risk factors for 90-day mortality in the multivariable regression model (HR:2.25; p<0.001) with the increased mortality risk 4.73 times (HR:4.73; p=0.002). Furthermore, a 1-unit increment of acute exacerbation increased the mortality risk 3.39 times (HR:3.39; p<0.001).

CONCLUSION

Our study showed that D-dimer/Fibrinogen ratio but not D-dimer and recurrent exacerbations after discharge might have a critical impact on 90-day mortality.

摘要

背景

根据世界卫生组织(WHO)的报告,到 2020 年,COPD 将成为全球第三大致死原因。

目的

我们旨在确定慢性阻塞性肺疾病急性加重(AECOPD)患者初次加重后 90 天死亡率的预后预测因素。

结果

Charlson 合并症评分(CCS)升高(HR:1.47;p<0.05)、初次加重后再入院(HR:1.47;p<0.05)是多变量回归模型中 30 天死亡率的预测危险因素。90 天死亡率为 11.8%。高血压、年龄中位数升高、营养风险评分(NRS)、CCS、CAT 评分和 mMRC 第 4 级是 90 天死亡率的可能危险因素。D-二聚体/纤维蛋白原比值>0.11 和≤0.11 的患者死亡率存在显著差异(HR:2.47;p<0.05)。出院后再次加重是多变量回归模型中 90 天死亡率的预测危险因素(HR:2.25;p<0.001),死亡率风险增加 4.73 倍(HR:4.73;p=0.002)。此外,急性加重程度增加 1 个单位会使死亡率风险增加 3.39 倍(HR:3.39;p<0.001)。

结论

我们的研究表明,D-二聚体/纤维蛋白原比值而非 D-二聚体和出院后再次加重可能对 90 天死亡率有重要影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/452c/8893003/e36a454ffe1f/MMJ3304-0276Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/452c/8893003/e36a454ffe1f/MMJ3304-0276Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/452c/8893003/e36a454ffe1f/MMJ3304-0276Fig1.jpg

相似文献

1
D-dimer/Fibrinogen ratio and recurrent exacerbations might have a potential impact to predict 90-day mortality in patients with COPD exacerbation.D-二聚体/纤维蛋白原比值与复发性加重可能对预测 COPD 加重患者 90 天死亡率有潜在影响。
Malawi Med J. 2021 Dec;33(4):276-280. doi: 10.4314/mmj.v33i4.8.
2
Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.D-二聚体对慢性阻塞性肺疾病急性加重期患者住院及1年死亡率的预后作用
Int J Chron Obstruct Pulmon Dis. 2016 Oct 31;11:2729-2736. doi: 10.2147/COPD.S112882. eCollection 2016.
3
D-dimer as a prognostic biomarker for mortality in chronic obstructive pulmonary disease exacerbation.D-二聚体作为慢性阻塞性肺疾病加重患者死亡率的预后生物标志物。
Am J Med Sci. 2015 Jan;349(1):29-35. doi: 10.1097/MAJ.0000000000000332.
4
Detection and study of plasma D-dimer change in patients with acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期患者血浆D-二聚体变化的检测与研究
J Biol Regul Homeost Agents. 2016 Jul-Sep;30(3):839-845.
5
In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.首次因慢性阻塞性肺疾病急性加重住院患者的院内及一年死亡率及其预测因素:一项基于全国人口的研究。
PLoS One. 2014 Dec 9;9(12):e114866. doi: 10.1371/journal.pone.0114866. eCollection 2014.
6
Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations.慢性阻塞性肺疾病评估测试:在监测康复和预测加重后疾病不良进程方面的作用。
Emergencias. 2019 Feb;31(1):21-26.
7
Utility of the CAT in the therapy assessment of COPD exacerbations in China.CAT 在 COPD 加重期中国治疗评估中的作用。
BMC Pulm Med. 2014 Mar 11;14:42. doi: 10.1186/1471-2466-14-42.
8
Determining prognosis in acute exacerbation of COPD.慢性阻塞性肺疾病急性加重期的预后判定
Int J Chron Obstruct Pulmon Dis. 2017 Jan 31;12:467-475. doi: 10.2147/COPD.S122382. eCollection 2017.
9
COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.在Humana医疗保险成员中,慢性阻塞性肺疾病(COPD)急性加重与改良的医学研究委员会量表及COPD评估测试的相关性。
Int J Chron Obstruct Pulmon Dis. 2016 Jan 14;11:111-21. doi: 10.2147/COPD.S94323. eCollection 2016.
10
Fibrin degradation products and survival in patients with chronic obstructive pulmonary disease: a protocolized prospective observational study.纤维蛋白降解产物与慢性阻塞性肺疾病患者生存状况的关系:一项前瞻性观察研究方案
Respir Res. 2023 Jun 27;24(1):172. doi: 10.1186/s12931-023-02472-9.

引用本文的文献

1
Effective new predictors of prognosis and comparison of multidisciplinary treatment options in acute mesenteric ischemia.急性肠系膜缺血预后的有效新预测指标及多学科治疗方案比较
North Clin Istanb. 2025 Apr 28;12(2):162-172. doi: 10.14744/nci.2023.82231. eCollection 2025.
2
A retrospective cohort study on a novel marker to predict the severity and prognosis of acute cerebral venous thrombosis: D-dimer to fibrinogen ratio.一项关于预测急性脑静脉血栓形成严重程度和预后的新型标志物:D-二聚体与纤维蛋白原比值的回顾性队列研究。
Thromb J. 2024 Oct 30;22(1):95. doi: 10.1186/s12959-024-00664-x.
3
Correlation of Serum Clara Cell Secretory Protein 16, Plasma Fibrinogen and Serum Amyloid A with the Severity of Acute Exacerbated COPD and Their Combination in Prognosis Assessment.

本文引用的文献

1
Novel pharmacological strategies to treat cognitive dysfunction in chronic obstructive pulmonary disease.治疗慢性阻塞性肺疾病认知功能障碍的新型药理学策略。
Pharmacol Ther. 2022 May;233:108017. doi: 10.1016/j.pharmthera.2021.108017. Epub 2021 Oct 7.
2
Trends in Incidence, and Mortality of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the United States Emergency Department (2010-2018).美国急诊科慢性阻塞性肺疾病急性加重的发病率和死亡率趋势(2010-2018 年)。
COPD. 2021 Oct;18(5):567-575. doi: 10.1080/15412555.2021.1979500. Epub 2021 Sep 16.
3
Employment Status, Readmission and Mortality After Acute Exacerbation of COPD.
血清克拉拉细胞分泌蛋白 16、血浆纤维蛋白原和血清淀粉样蛋白 A 与急性加重 COPD 严重程度的相关性及其联合对预后评估的价值。
Int J Chron Obstruct Pulmon Dis. 2023 Sep 6;18:1949-1957. doi: 10.2147/COPD.S410917. eCollection 2023.
4
Fibrin degradation products and survival in patients with chronic obstructive pulmonary disease: a protocolized prospective observational study.纤维蛋白降解产物与慢性阻塞性肺疾病患者生存状况的关系:一项前瞻性观察研究方案
Respir Res. 2023 Jun 27;24(1):172. doi: 10.1186/s12931-023-02472-9.
COPD 急性加重后就业状况、再入院和死亡率。
Int J Chron Obstruct Pulmon Dis. 2021 Aug 5;16:2257-2265. doi: 10.2147/COPD.S319840. eCollection 2021.
4
Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction.慢性阻塞性肺疾病:从缓解症状到降低死亡率
Ther Adv Chronic Dis. 2021 May 13;14:20406223211014028. doi: 10.1177/20406223211014028. eCollection 2021.
5
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact.慢性阻塞性肺疾病恶化基础:诊断、治疗、预防和疾病影响。
Respirology. 2021 Jun;26(6):532-551. doi: 10.1111/resp.14041. Epub 2021 Apr 24.
6
Impact of Frailty on the Risk of Exacerbations and All-Cause Mortality in Elderly Patients with Stable Chronic Obstructive Pulmonary Disease.衰弱对老年稳定期慢性阻塞性肺疾病患者加重风险和全因死亡率的影响。
Clin Interv Aging. 2021 Apr 13;16:593-601. doi: 10.2147/CIA.S303852. eCollection 2021.
7
Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus.急性住院加重期 COPD 的临床评估、管理和随访的标准化:一项欧洲范围的共识。
Int J Chron Obstruct Pulmon Dis. 2021 Feb 16;16:321-332. doi: 10.2147/COPD.S287705. eCollection 2021.
8
Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio.慢性阻塞性肺疾病(COPD)严重加重和死亡率的预测:加重病史及吸气容量/肺总量比值的作用
Int J Chron Obstruct Pulmon Dis. 2018 Apr 5;13:1105-1113. doi: 10.2147/COPD.S155848. eCollection 2018.
9
One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease.因慢性阻塞性肺疾病住院患者的一年期及长期死亡率。
J Thorac Dis. 2017 Mar;9(3):636-645. doi: 10.21037/jtd.2017.03.34.
10
Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.D-二聚体对慢性阻塞性肺疾病急性加重期患者住院及1年死亡率的预后作用
Int J Chron Obstruct Pulmon Dis. 2016 Oct 31;11:2729-2736. doi: 10.2147/COPD.S112882. eCollection 2016.